Pharmacological interventions for the treatment of smokeless tobacco use.

Author: EbbertJon O, FagerstromKarl

Paper Details 
Original Abstract of the Article :
Smokeless tobacco (SLT) is used in a variety of forms throughout the world. Long-term SLT use is associated with adverse health consequences. Effective pharmacotherapies are needed to treat SLT users who want to achieve tobacco abstinence. In the current review, we discuss the pharmacological interv...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.2165/11598450-000000000-00000

データ提供:米国国立医学図書館(NLM)

Pharmacological Interventions for Smokeless Tobacco Use: Breaking the Habit

The desert of tobacco addiction can be a tough place to navigate, with smokeless tobacco (SLT) posing a significant health risk. This study reviews the available pharmacological interventions for treating SLT use. The researchers reviewed existing studies and found that nicotine replacement therapy (NRT), bupropion, and varenicline can be helpful in reducing SLT use and supporting abstinence. However, the effectiveness of these medications varies depending on the specific formulation and individual patient factors.

Pharmacological Tools for Smokeless Tobacco Cessation

The study's findings suggest that pharmacological interventions, such as NRT, bupropion, and varenicline, can play a role in treating SLT use. However, it's crucial to consult with a healthcare professional to determine the most effective treatment strategy for each individual.

Finding the Right Path to Quitting

Individuals struggling with SLT use should explore various treatment options and discuss their options with a healthcare professional to create a personalized plan for quitting.

Dr.Camel's Conclusion

This study provides a comprehensive overview of pharmacological interventions for SLT use, emphasizing the importance of personalized care and tailoring treatment strategies to meet individual needs.

Date :
  1. Date Completed 2012-08-27
  2. Date Revised 2021-10-21
Further Info :

Pubmed ID

22136150

DOI: Digital Object Identifier

10.2165/11598450-000000000-00000

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.